Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
83 LiuW
Shen, Lixin
(1999) RACK1, a protein kinase C anchoring protein, coordinates the binding of activated protein kinase C and select pleckstrin homology domains in vitro
My medication arrived via one-day shipping in insulated packaging with ice packs, dry ice, and a clear barrier between cold packs and materials
Clinical Applications While human trials are limited and 5-Amino-1MQ is not FDA-approved as a therapeutic agent, its mechanism and early research suggest potential benefits in: Weight management and body recomposition Adiposity reduction and fat loss Insulin sensitivity improvement Metabolic syndrome support NAD optimization and anti-aging protocols Cellular energy and endurance enhancement Adjunct to exercise or caloric restriction protocols It may be particularly relevant for individuals with stubborn fat loss resistance , age-related metabolic decline, or those using NAD-supportive therapies like NMN or NR
When to Seek Clinical Attention: Safety Boundaries and Provider Guidance While mild dizziness during dose adjustment is common, persistent dizziness lasting more than 4 weeks, dizziness accompanied by chest pain or shortness of breath, or severe episodes causing falls require immediate medical evaluation
